Gender, Estrogen, and NOS
1999; Lippincott Williams & Wilkins; Volume: 85; Issue: 11 Linguagem: Alemão
10.1161/01.res.85.11.979
ISSN1524-4571
Autores Tópico(s)Birth, Development, and Health
ResumoHomeCirculation ResearchVol. 85, No. 11Gender, Estrogen, and NOS Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBGender, Estrogen, and NOS Cautions About Generalizations Virginia M. Miller Virginia M. MillerVirginia M. Miller From the Departments of Surgery and Physiology, The Mayo Clinic and Foundation, Rochester, Minn. Originally published26 Nov 1999https://doi.org/10.1161/01.RES.85.11.979Circulation Research. 1999;85:979–981Evidence from observational studies as well as prospective randomized trials indicates that the incidence of coronary artery disease is less in premenopausal women compared with age-matched men and in postmenopausal women who are using estrogen replacement therapy.12 The mechanisms by which estrogen reduces development of cardiovascular disease are multifactorial and, in addition to alterations in lipid metabolism, include actions on all components of the vascular wall (endothelial, smooth muscle, and adventitial cells), neurons, and blood elements (platelets and leukocytes). Changes in production of nitric oxide (NO) have been implicated as one of the cellular biochemical-related pathways regulated by estrogen that may contribute to gender and hormonal differences in the progression of cardiovascular disease.3456789 NO is synthesized from l-arginine by the enzyme nitric oxide synthase (NOS). NOS consists of three isoforms: type I, neuronal; type II, inducible; and type III, endothelial/constitutive. In this issue of Circulation Research, García-Durán et al10 add to the accumulating body of evidence suggesting that estrogen directly modulates expression of NOS, in particular the neuronal isoform (type I) in neutrophils. With use of Western blot analysis of protein isolated from neutrophils, levels of neuronal NOS were greater in neutrophils from premenopausal women during the ovulatory phase of the estrus cycle when estrogen is high compared with the follicular phase when circulating levels of estrogen fall. In addition, expression of neuronal NOS increased in neutrophils of postmenopausal women who were using transdermal estrogen replacement (50 mg/d) for 4 months. The range of circulating estrogen over which these changes in neuronal NOS occurred was physiological, between 5×10−10 and 2×10−9 mol/L. These observations suggest that changes in circulating levels of oxidized products of nitric oxide in blood of women during different stages of the estrus cycle as well as with estrogen replacement therapy may be derived from cells other than the those of the endothelium.11121314García-Durán et al10 examined the gender specificity of estrogen on expressional control of neuronal NOS using neutrophils from male subjects. In these cells, there was both a time and dose dependency of induction of neuronal NOS by estrogen. This induction was receptor mediated and showed biphasic stimulation with increases in NOS from 10−10 to 10−8 mol/L of estrogen and inhibition at higher concentrations. These concentration ranges are similar to those shown to stimulate neuronal NOS isolated from rabbit cerebellum.15 The observation that estrogen can modulate NOS isoform in male cells is consistent with observations of increases in reactive hyperemia, a vascular response mediated by endothelium-derived NOS, in male to female transsexuals.16As provocative as these results might be, much remains to be learned regarding effects of sex steroid hormones on leukocyte function and how these effects relate to gender differences in expression of cardiovascular or other diseases. Although the kinetics of the response of induction of neuronal NOS was defined for neutrophils isolated from males, the question arises as to whether the kinetic relationship of induction of neuronal NOS might be altered on a background of concentrations of endogenous hormones such as estrogen itself, progesterone, or testosterone, as has been reported for macrophages.17The physiological significance of modulation of NOS isoforms by estrogen remains to be tested definitively in different models of cardiovascular disease. Although mechanical vascular injury and high-cholesterol feeding are common manipulations in experimental animals to mimic the pathogenesis of cardiovascular disease in humans, few experimental studies are designed to examine relationships between cardiovascular disease and infections such as Chlamydia, cytomegalovirus, endocarditis, syphilis, or human immunodeficiency virus.18192021222324 Functionally, increased expression of neuronal NOS in male neutrophils correlated with increased production of NO, reduced expression of CD18 antigen, and reduced adhesion of neutrophils to a plastic surface. Decreased neutrophil adherence may not be "beneficial" when neutrophil infiltration is a first-line defense to limit infective processes. With immunological challenge, NO will be induced in cells other than neutrophils, and cytokines will increase expression of type II inducible NOS.2526 Because NOS is regulated by NO itself, increased production of NO from other isoforms, especially the inducible isoform, may in fact decrease NO production in other cell types independent of the mechanism by which that isoform of NOS may be upregulated by estrogen. Therefore, effects of modulation of NOS isoforms by estrogen should be considered in the context of integrated physiological function.Expressional control of neuronal NOS in male neutrophils seems to be initiated by receptor activation. However, the specific subtype of the estrogen receptor, that is, estrogen receptor α or β, was not identified. Expression of estrogen receptor β is upregulated in endothelial cells after injury to carotid arteries in male mice.27 The induction of specific estrogen receptors after injury or infection in other cell types remains to be determined. Estrogen modulates NO-mediated endothelium-dependent responses in experimental animals and in men lacking estrogen receptor α.282930 These observations suggest that estrogen receptors, other than estrogen receptor α, mediate responses to estrogen. Therefore, future experiments directed toward understanding differential regulation of estrogen receptors on specific cell types should be important for development of therapeutic selective estrogen receptor modulators (SERMs). For example, the SERM raloxifene, which has been approved for treatment of osteoporosis in women, has yet to be tested in men.3132 Cardiovascular effects of raloxifene are beginning to be defined in experimental animals, and favorable changes in serum biochemical markers of cardiovascular risk in postmenopausal women have been reported.2 Although raloxifene treatment reduced LDL in ovariectomized cynomolgus monkeys, it failed to reduce atherosclerosis in these animals as in cholesterol-fed rabbits.3334 How this SERM affects primary cardiovascular outcomes in women at increased risk for coronary disease awaits results of the RUTH (Raloxifene Use and The Heart) trial.2 Future experimental studies should address the specificity of SERMs on activation of NOS isoforms related to estrogen receptor affinity and efficacy in leukocytes from both male and female animals.353637In summary, the article by García-Durán et al10 provides an additional mechanism by which estrogen may affect physiological functions, in particular, function of neutrophils. However, caution is needed in extrapolating findings from studies performed on isolated cells to understanding how a particular action of estrogen may be involved in gender difference in the expression of human disease.38 Five issues should be considered: (1) genome (G); does the effect of a hormone apply to animals of XX and XY characterization, and/or might polymorphisms in expression of hormone receptors alter responsiveness of cells or animals to changes in hormone concentrations? (2) integrated physiology (I); are responses of individual cells to hormones modulated in the whole animal by endogenous hormones or cytokines that could either synergize or functionally antagonize effects of the hormones of specific cells? (3) receptors (R); how are the various subtypes of estrogen receptors modulated, and are the effects of the hormones initiated by receptor activation, genomic or nongenomic? (4) binding affinities of ligands (L) for the receptors; what are the affinities and efficacy for ligand binding in cells of male and female animals, and is this influenced by the endogenous levels of other hormones? (5) specificity of response (S); are the intracellular pathways activated by the hormone specific to a given type of cell? Individual experiments, for example, the one of García-Durán et al,10 begin to provide answers to important questions of how estrogen affects neutrophils in men and women. However, it is only when the GIRLS are included in design of experiments that results might begin to be related to how estrogen modulates development of infection-associated cardiovascular diseases in men and women.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.Dr Miller's research is funded in part by grants from the National Institutes of Health (HL51736), American Home Products, and the Mayo Foundation.FootnotesCorrespondence to Virginia M. Miller, PhD, The Mayo Clinic and Foundation, Departments of Surgery and Physiology, 200 First St SW, Rochester, MN 55905. E-mail [email protected] References 1 Oparil S. Hormones and vasoprotection. Hypertension.1999; 33:170–176.CrossrefMedlineGoogle Scholar2 Barrett-Connor E, Wenger NK, Grady D, Mosca L, Collins P, Kornitzer M, Cox DA, Moscarelli E, Anderson PW. Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene. J Womens Health.1998; 7:839–847.CrossrefMedlineGoogle Scholar3 Hayashi T, Yamada K, Esaki T, Muto E, Chaudhuri G, Iguchi A. Physiological concentrations of 17β-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. J Cardiovasc Pharmacol.1998; 31:292–298.CrossrefMedlineGoogle Scholar4 Hayashi T, Yamada K, Esaki T, Mutoh E, Iguchi A. Effect of estrogen on isoforms of nitric oxide synthase: possible mechanism of anti-atherosclerotic effect of estrogen. Gerontology.1997; 43:24–34.CrossrefMedlineGoogle Scholar5 Zhong C, Yuhanna IS, Zoya G-G, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor-α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest.1999; 103:401–406.CrossrefMedlineGoogle Scholar6 Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett.1995; 360:291–293.CrossrefMedlineGoogle Scholar7 Kauser K, Sonnenberg D, Diel P, Rubanyi GM. Effect of 17β-oestradiol on cytokine-induced nitric oxide production in rat isolated aorta. Br J Pharmacol.1998; 123:1089–1096.CrossrefMedlineGoogle Scholar8 White CR, Shelton J, Chen S-J, Darley-Usmar V, Allen L, Nabors C, Sanders PW, Chen Y-F, Oparil S. Estrogen restores endothelial cell function in an experimental model of vascular injury. Circulation.1998; 96:1624–1630.Google Scholar9 Caulin-Glaster T, Garcia-Cardena G, Sarrel P, Sessa WC, Bender JR. 17β-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ Res.1997; 81:885–892.CrossrefMedlineGoogle Scholar10 García-Durán M, de Frutos T, Díaz-Recasens J, García-Gálvez G, Jiménez A, Montón M, Farré J, Sánchez de Miguel L, González-Fernández F, del Mar Arriero M, Rico L, García R, Casado S, López-Farré A. Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils. Circ Res.1999; 85:1020–1026.CrossrefMedlineGoogle Scholar11 Cicinelli E, Ignarro LJ, Lograno M, Galantino P, Balzano G, Schonauer LM. Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle. Fertil Steril.1996; 66:1036–1038.CrossrefMedlineGoogle Scholar12 Cicinelli E, Ignarro LJ, Lograno M, Matteo G, Falco N, Schonauer LM. Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil Steril.1997; 67:63–66.CrossrefMedlineGoogle Scholar13 Cicinelli E, Ignarro LJ, Schonauer LM, Matteo MG, Galantino P, Balzano G. Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil Steril.1998; 69:58–61.CrossrefMedlineGoogle Scholar14 Best PJM, Berger PB, Miller VM, Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med.1998; 128:285–288.CrossrefMedlineGoogle Scholar15 Hayashi T, Ishikawa T, Yamada K, Kuzuya M, Naito M, Hidaka H, Iguchi A. Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca2+-calmodulin dependent mechanism. Biochem Biophys Res Commun.1994; 203:1013–1019.CrossrefMedlineGoogle Scholar16 New G, Timmins KL, Duffy SJ, Tran BT, O'Brien RC, Harper RW, Meredith IT. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol.1997; 29:1437–1444.CrossrefMedlineGoogle Scholar17 Miller L, Hunt JS. Sex steroid hormones and macrophage function. Life Sci.1996; 59:1–14.MedlineGoogle Scholar18 Gibbs RGJ, Carey N, Davies AH. Chlamydia pneumoniae and vascular disease. Br J Surg.1998; 85:1191–1197.CrossrefMedlineGoogle Scholar19 Pomerance A, Yacoub MH, Gula G. The surgical pathology of thoracic aortic aneurysms. Histopathology.1977; 1:257–276.CrossrefMedlineGoogle Scholar20 Zhou YF, Shou M, Guetta E, Guzman R, Unger EF, Zu XY, Zhang J, Finkel T, Epstein SE. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation.1999; 100:1569–1575.CrossrefMedlineGoogle Scholar21 Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, Kuo CC. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis.1999; 180:238–241.CrossrefMedlineGoogle Scholar22 Gott VL, Gillinov AM, Pyeritz RE, Cameron DE, Reitz BA, Greene PS, Stone CD, Ferris RL, Alejo DE, McLarty AJ. Aortic root replacement. Risk factor analysis of a seventeen-year experience with 270 patients. J Thorac Cardiovasc Surg.1995; 109:536–544.CrossrefMedlineGoogle Scholar23 Tornos MP, Olona M, Permanyer-Miralda G, Almirante B, Evangelista A, Soler-Soler J. Is the clinical spectrum and prognosis of native valve infective endocarditis in non-addicts changing? Eur Heart J.1995; 16:1686–1691.CrossrefMedlineGoogle Scholar24 Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol.1996; 49:1149–1154.CrossrefMedlineGoogle Scholar25 Spitzer JA, Zhang P. Gender differences in neutrophil function and cytokine-induced neutrophil chemoattractant generation in endotoxic rats. Inflammation.1996; 20:485–498.CrossrefMedlineGoogle Scholar26 Grohe C, Kahlert S, Lobbert K, Vetter H. Expression of oestrogen receptor α and β in rat heart: role of local oestrogen synthesis. J Endocrinol.1998; 156:R1–R7.CrossrefMedlineGoogle Scholar27 Lindner V, Kim SK, Karas RH, Kuiper GGM, Gustafsson J-A, Mendelsohn ME. Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res.1998; 83:224–229.CrossrefMedlineGoogle Scholar28 Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, O'Donnell TF Jr, Korach KS, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nat Med.1997; 3:545–548.CrossrefMedlineGoogle Scholar29 Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, Korach KS. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and the effect of estrogen receptor gene disruption. J Clin Invest.1997; 99:2429–2437.CrossrefMedlineGoogle Scholar30 Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K, Rubanyi GM. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet.1997; 349:1146–1147.CrossrefMedlineGoogle Scholar31 Balfour JA, Goa KL. Raloxifene. Drugs Aging.1998; 12:335–341.CrossrefMedlineGoogle Scholar32 Raloxifene approval ushers in new drug class for osteoporosis. Estrogen-receptor effects vary by tissue type. Am J Health Syst Pharm.1998; 55:104.CrossrefMedlineGoogle Scholar33 Bjarnason NH, Haarbo J, Byrjalsen I, Kauffman RF, Christiansen C. Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits. Circulation.1998; 96:1964–1969.Google Scholar34 Clarkson TB, Anthony MS, Jerome CP. Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys. J Clin Endocrinol Metab.1998; 83:721–726.MedlineGoogle Scholar35 Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol Pharmacol.1998; 54:105–112.CrossrefMedlineGoogle Scholar36 Nikezie-Ardolic M, Lin L, Milcevic M, Zakeri Z. Gender differences in cellular response. Lupus.1999; 8:375–379.CrossrefMedlineGoogle Scholar37 Ostrer H. Sex-based differences in gene transmission and gene expression. Lupus.1999; 8:365–369.CrossrefMedlineGoogle Scholar38 Gabriel SE. The epidemiology of gender-discrepant illness. Lupus.1999; 8:339–345.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Carter J, Madamanchi N, Stouffer G, Runge M, Cascio W and Tong H (2017) Ultrafine particulate matter exposure impairs vasorelaxant response in superoxide dismutase 2-deficient murine aortic rings, Journal of Toxicology and Environmental Health, Part A, 10.1080/15287394.2017.1420504, 81:5, (106-115), Online publication date: 4-Mar-2018. Quinteiro H, Buzin M, Conti F, Dias D, Figueroa D, Llesuy S, Irigoyen M, Sanches I and De Angelis K (2015) Aerobic exercise training promotes additional cardiac benefits better than resistance exercise training in postmenopausal rats with diabetes, Menopause, 10.1097/GME.0000000000000344, 22:5, (534-541), Online publication date: 1-May-2015. Fan G, Zhu Y, Guo H, Wang X, Wang H and Gao X (2011) Direct Vasorelaxation by a Novel Phytoestrogen Tanshinone IIA Is Mediated by Nongenomic Action of Estrogen Receptor Through Endothelial Nitric Oxide Synthase Activation and Calcium Mobilization, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0b013e31820a0da1, 57:3, (340-347), Online publication date: 1-Mar-2011. Pérez-Torres I, El Hafidi M, Infante O and Baños G (2008) Effects of sex hormone levels on aortic vascular reactivity and variables associated with the metabolic syndrome in sucrose-fed female rats, Canadian Journal of Physiology and Pharmacology, 10.1139/Y07-113, 86:1-2, (25-35), Online publication date: 1-Jan-2008. Peroni R, Orliac M, Abramoff T, Ribeiro M, Franchi A and Adler-Graschinsky E (2007) Participation of CGRP and prostanoids in the sex-linked differences of vascular anandamide effects in mesenteric beds of Sprague-Dawley rats, European Journal of Pharmacology, 10.1016/j.ejphar.2006.11.012, 557:1, (49-57), Online publication date: 1-Feb-2007. Torres I, Hafidi M, Zamora-González J, Infante O, Chavira R and Baños G (2007) Modulation of aortic vascular reactivity by sex hormones in a male rat model of metabolic syndrome, Life Sciences, 10.1016/j.lfs.2007.04.006, 80:23, (2170-2180), Online publication date: 1-May-2007. Malorni W, Campesi I, Straface E, Vella S and Franconi F (2007) Redox Features of the Cell: A Gender Perspective, Antioxidants & Redox Signaling, 10.1089/ars.2007.1596, 9:11, (1779-1802), Online publication date: 1-Nov-2007. Doshida M, Ohmichi M, Tsutsumi S, Kawagoe J, Takahashi T, Du B, Mori-Abe A, Ohta T, Saitoh-Sekiguchi M, Takahashi K and Kurachi H (2006) Raloxifene Increases Proliferation and Up-regulates Telomerase Activity in Human Umbilical Vein Endothelial Cells, Journal of Biological Chemistry, 10.1074/jbc.M513251200, 281:34, (24270-24278), Online publication date: 1-Aug-2006. Huang Y, Huang W, Lin W, Chen M and Jeng S (2006) An endothelial-cell-enriched primary culture system to study vascular endothelial growth factor (VEGF A) expression in a teleost, the Japanese eel (Anguilla japonica), Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 10.1016/j.cbpa.2006.04.027, 145:1, (33-46), Online publication date: 1-Sep-2006. Shaul P and Chambliss K (2005) Chapter 6 Caveolae and Estrogen Receptor Signaling Caveolae and Lipid Rafts: Roles in Signal Transduction and the Pathogenesis of Human Disease, 10.1016/S1569-2558(05)36006-1, (109-123), . Korstjens I, Smolders R, van der Mooren M, Kloosterboer H, Kenemans P and Sipkema P (2005) Endothelium-dependent dilatory effects of 3α-OH-tibolone in gracilis muscle arterioles of the female Wistar rat, Menopause, 10.1097/01.GME.0000146714.59224.C1, 12:3, (340-347), Online publication date: 1-May-2005. Rush J, Turk J and Laughlin M (2003) Exercise training regulates SOD-1 and oxidative stress in porcine aortic endothelium, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00190.2002, 284:4, (H1378-H1387), Online publication date: 1-Apr-2003. Lee W, Xu Y, Fung S and Fung H (2003) eNOS-dependent vascular interaction between nitric oxide and calcitonin gene-related peptide in mice: gender selectivity and effects on blood aggregation, Regulatory Peptides, 10.1016/S0167-0115(02)00210-0, 110:2, (115-122), Online publication date: 1-Jan-2003. Laughlin M, Welshons W, Sturek M, Rush J, Turk J, Taylor J, Judy B, Henderson K and Ganjam V (2003) Gender, exercise training, and eNOS expression in porcine skeletal muscle arteries, Journal of Applied Physiology, 10.1152/japplphysiol.00061.2003, 95:1, (250-264), Online publication date: 1-Jul-2003. Staykova M, Cowden W and Willenborg D (2002) Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation, Immunology & Cell Biology, 10.1046/j.1440-1711.2002.01072.x, 80:2, (188-197), Online publication date: 1-Apr-2002. Chambliss K and Shaul P (2002) Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae, Steroids, 10.1016/S0039-128X(01)00177-5, 67:6, (413-419), Online publication date: 1-May-2002. Christopher T, Lopez B, Stillwagon J, Gao F, Gao E, Ma X, Ohlstein E and Yue T (2002) Idoxifene causes endothelium-dependent, nitric oxide-mediated vasorelaxation in male rats, European Journal of Pharmacology, 10.1016/S0014-2999(02)01821-6, 446:1-3, (139-143), Online publication date: 1-Jun-2002. Hisamoto K, Ohmichi M, Kanda Y, Adachi K, Nishio Y, Hayakawa J, Mabuchi S, Takahashi K, Tasaka K, Miyamoto Y, Taniguchi N and Murata Y (2001) Induction of Endothelial Nitric-oxide Synthase Phosphorylation by the Raloxifene Analog LY117018 Is Differentially Mediated by Akt and Extracellular Signal-regulated Protein Kinase in Vascular Endothelial Cells, Journal of Biological Chemistry, 10.1074/jbc.M103853200, 276:50, (47642-47649), Online publication date: 1-Dec-2001. Ma X, Gao F, Chen J, Christopher T, Lopez B, Ohlstein E and Yue T (2001) Endothelial protective and antishock effects of a selective estrogen receptor modulator in rats, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.2001.280.2.H876, 280:2, (H876-H884), Online publication date: 1-Feb-2001. Laughlin M, Schrage W, McAllister R, Garverick H and Jones A (2001) Interaction of gender and exercise training: vasomotor reactivity of porcine skeletal muscle arteries, Journal of Applied Physiology, 10.1152/jappl.2001.90.1.216, 90:1, (216-227), Online publication date: 1-Jan-2001. Harada H, Pavlick K, Hines I, Hoffman J, Bharwani S, Gray L, Wolf R and Grisham M (2001) Selected Contribution: Effects of gender on reduced-size liver ischemia and reperfusion injury, Journal of Applied Physiology, 10.1152/jappl.2001.91.6.2816, 91:6, (2816-2822), Online publication date: 1-Dec-2001. November 26, 1999Vol 85, Issue 11 Advertisement Article InformationMetrics © 1999 American Heart Association, Inc.https://doi.org/10.1161/01.RES.85.11.979 Originally publishedNovember 26, 1999 Keywordsgendernitric oxidehormones, male, femaleinfectionPDF download Advertisement
Referência(s)